- SGMO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Sangamo Therapeutics (SGMO) 10-K/A2017 FY Annual report (amended)
Filed: 24 Apr 18, 12:00am
Exhibit 31.4
PRINCIPAL FINANCIAL OFFICER CERTIFICATE
I, Kathy Y. Yi, certify that:
1. | I have reviewed this amendment no. 1 to the annual report on Form10-K of Sangamo Therapeutics, Inc. (the “registrant”); and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 24, 2018 |
/s/ Kathy Y. Yi |
Kathy Y. Yi |
Executive Vice President and Chief Financial Officer |
(Principal Financial and Accounting Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.